Skip to main content

Part of the book series: Developments in Hematology and Immunology ((DIHI,volume 33))

  • 82 Accesses

Abstract

A novel platelet substitute Synthocytes is being developed for the treatment and prevention of bleeding in acute thrombocytopenia. Synthocytes are composed of microcapsules of human serum albumin (HSA) to which human fibrinogen is immobilised. The product is manufactured using virally inactivated human blood derived proteins and is formulated as a sterile pyrogen free lyophilised preparation. The potential advantages of Synthocytes over platelet transfusion include a reduced risk of blood borne virus transmission, no risk of alloimmunogenic reactions, an increased shelf life and therefore a more cost effective, more easily managed therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Sullam PM, Frank U, Yeaman MR, Tauber MG, Bayer AS, Chambers HF. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Inf Dis 1993; 168:910–914.

    Article  CAS  Google Scholar 

  2. Levi M. Written communication. 1997.

    Google Scholar 

  3. Sakariassen KS, Aarts PAMM, de Groot PhG, Houdijk WP, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix and purified components. J Lab Clin Med 1983;102:522–535.

    PubMed  CAS  Google Scholar 

  4. De Groot PhG. Written communication. 1997.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Middleton, S.M. (1998). The Development of Synthocytes, a Novel Platelet Substitute. In: Sibinga, C.T.S., Das, P.C., Fratantoni, J.C. (eds) Alternative Approaches to Human Blood Resources in Clinical Practice. Developments in Hematology and Immunology, vol 33. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5619-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5619-0_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7571-5

  • Online ISBN: 978-1-4615-5619-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics